| First Author | Horiuchi H | Year | 2015 |
| Journal | PLoS One | Volume | 10 |
| Issue | 3 | Pages | e0118640 |
| PubMed ID | 25794104 | Mgi Jnum | J:229575 |
| Mgi Id | MGI:5752456 | Doi | 10.1371/journal.pone.0118640 |
| Citation | Horiuchi H, et al. (2015) Interleukin-19 acts as a negative autocrine regulator of activated microglia. PLoS One 10(3):e0118640 |
| abstractText | Activated microglia can exert either neurotoxic or neuroprotective effects, and they play pivotal roles in the pathogenesis and progression of various neurological diseases. In this study, we used cDNA microarrays to show that interleukin-19 (IL-19), an IL-10 family cytokine, is markedly upregulated in activated microglia. Furthermore, we found that microglia are the only cells in the nervous system that express the IL-19 receptor, a heterodimer of the IL-20Ralpha and IL-20Rbeta subunits. IL-19 deficiency increased the production of such pro-inflammatory cytokines as IL-6 and tumor necrosis factor-alpha in activated microglia, and IL-19 treatment suppressed this effect. Moreover, in a mouse model of Alzheimer's disease, we observed upregulation of IL-19 in affected areas in association with disease progression. Our findings demonstrate that IL-19 is an anti-inflammatory cytokine, produced by activated microglia, that acts negatively on microglia in an autocrine manner. Thus, microglia may self-limit their inflammatory response by producing the negative regulator IL-19. |
